New diabetes clinical trial: Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.

Published on: February 12, 2026 at 11:00PM
Conditions: Muscle Wasting; Obesity & Overweight; Obesity
Interventions: Drug: BIO101; Other: Placebo; Drug: Semaglutide
Sponsors: Biophytis
Not yet recruiting
https://ift.tt/Ehb9wZU